USANA Health Sciences (NYSE: USNA) reported Q2 EPS of $2.07, $0.02 better than the analyst estimate of $2.05. Revenue for the quarter came in at $258.5 million versus the consensus estimate of $256.66 million.

For earnings history and earnings-related data on USANA Health Sciences (USNA) click here.